Akebia Therapeutics, Inc. (AKBA)
Share Price Chart
The chart shows the growth of $10,000 invested in Akebia Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $239 for a total return of roughly -97.61%. All prices are adjusted for splits and dividends.
Compare to other instruments
Akebia Therapeutics, Inc. had a return of 10.75% year-to-date (YTD) and -74.13% in the last 12 months. Over the past 10 years, Akebia Therapeutics, Inc. had an annualized return of -33.93%, while the S&P 500 had an annualized return of 8.71%, indicating that Akebia Therapeutics, Inc. did not perform as well as the benchmark.
|5 years (annualized)||-42.88%||8.95%|
|10 years (annualized)||-33.93%||8.71%|
Monthly Returns Heatmap
Akebia Therapeutics, Inc. doesn't pay dividends
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below shows the maximum drawdowns of the Akebia Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Akebia Therapeutics, Inc. is 99.14%, recorded on Nov 17, 2022. The portfolio has not recovered from it yet.
|-99.14%||Jun 23, 2014||2119||Nov 17, 2022||—||—||—|
|-36.84%||Mar 21, 2014||16||Apr 11, 2014||5||Apr 21, 2014||21|
|-21.82%||Apr 22, 2014||20||May 19, 2014||14||Jun 9, 2014||34|
|-4.91%||Jun 10, 2014||6||Jun 17, 2014||3||Jun 20, 2014||9|
Current Akebia Therapeutics, Inc. volatility is 107.98%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.